Topiramate 70710-1042
Product NDC
70710-1042- Manufacturer
- Zydus Pharmaceuticals Usa Inc.
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 17, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA208949
Need to source Topiramate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Topiramate | 150 mg/1 |
Drug Class
Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 3A4 Inducers [MoA]Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(2)
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70710-1042-3)
90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70710-1042-9)